A surge in cases of a rare autoimmune disease during COVID-19 waves in England led to the discovery of a new syndrome. When you purchase through links on our site, we may earn an affiliate commission.

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung ...

For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown. Stereotactic ablative radiotherapy (SABR) has ...

Harish Narasimhan receives funding from the National Heart, Lung, and Blood Institute at the National Institutes of Health, USA. The long-term effects of respiratory viral infections such as COVID-19 ...

In a study published this week in JCI Insight, Dr. Ankit Bharat, director of the Northwestern Medicine Canning Thoracic Institute, laid out how abnormal cells emerge and work to cause lung damage and ...

Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.

If you’ve been coughing for weeks, blaming it on “lingering winter sniffles” or chalking it up to “just getting older,” it might be time to step away from the cough syrup and lean in for some ...

Researchers have discovered a new autoimmune syndrome associated with COVID-19 that can cause life-threatening lung disease. The syndrome — which scientists have dubbed "MDA5-autoimmunity and ...